Clinical trials: Trypanosoma Brucei Gambiense; Infection

African Trypanosomiasis

Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

• Completed
• Age: 15 to 50 years
• Phase 2

Human African Trypanosomiasis or sleeping sickness has made a spectacular return during the last decade, and in many places the demand largely surpasses the capacities of the treatment centers.

Trial name

NCT00803933

Testing

DB289, Pentamidine

Where

2 sites in Republic of the Congo

Volunteers

111 people

Sponsor

Immtech Pharmaceuticals, Inc